Aquestive Therapeutics, Inc.

AQST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 23, 2026 PRIMARY DOCUMENT
8-K Oct 19, 2026 8-K
4 Oct 16, 2026 PRIMARY DOCUMENT
3 Oct 16, 2026 PRIMARY DOCUMENT
8-K Oct 15, 2026 8-K
8-K Oct 14, 2026 8-K
SCHEDULE 13G Oct 7, 2026
SCHEDULE 13G/A Oct 7, 2026
8-K Sep 29, 2026 8-K
8-K Sep 25, 2026 8-K
8-K Sep 17, 2026 8-K
4 Sep 16, 2026 PRIMARY DOCUMENT
144 Sep 15, 2026
4 Sep 11, 2026 PRIMARY DOCUMENT
4 Sep 10, 2026 PRIMARY DOCUMENT
4 Sep 9, 2026 PRIMARY DOCUMENT
144 Sep 9, 2026
4 Sep 8, 2026 PRIMARY DOCUMENT
4 Aug 18, 2026 PRIMARY DOCUMENT
4 Aug 17, 2026 PRIMARY DOCUMENT
144 Aug 17, 2026
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
8-K Aug 10, 2026 8-K
SCHEDULE 13G/A Jul 27, 2026
← Newer Page 1 of 28 · 683 filings Older →